Clinical Trials Browser

Phase 2/3 × Terminated × Esophageal Neoplasms × Clear all

Esophageal Neoplasms, Lung Neoplasms

NCT01704690 2017-04-07

Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer

Phase 2/3 Terminated

4 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT00332280 2013-03-20

Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo

Phase 2/3 Terminated

67 enrolled

GastrointestinalGenitourinaryThoracic

Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Genital Neoplasms, Female, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms

Clinical Trials

POPP

Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer

Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo